A higher risk of liver transplant and death was observed in Ocaliva-treated patients vs those who received placebo.

Interim data from a phase 3 study evaluating tecovirimat for the treatment of human mpox virus showed the antiviral did not improve time to lesion resolution compared with placebo.

The FDA is expected to decide on treatments for EBV-positive posttransplant lymphoproliferative disease, breast cancer, Barth syndrome, pain, and migraine.

At all time points, consistently high levels of patient satisfaction were observed (>84% reporting much or very much improved).

Adults with asthma with cost-related medication nonadherence more likely to have asthma attacks, ED visits for asthma ...

Findings seen among children and adolescents with type 1 diabetes and nonoptimal control with traditional treatment ...

The sBLA submission included results from the randomized, parallel-arm, placebo-controlled and active-controlled trial foresiGHt.

The double-blind, placebo-controlled STOPMD-3 trial enrolled 221 patients aged 18 to 75 years with a history of Meniere disease and active symptoms.

Compared with placebo, obicetrapib lowered LDL-C by 33% at day 84 ( P <.0001). Changes in other biomarkers, including high-density lipoprotein cholesterol (HDL-C), non-HDL-C, lipoprotein (a), ...

Number of people with at least one episode of HSV-attributable genital ulcer disease was 187.9 and 16.7 million for HSV-2, HSV-1 in 2020 ...

(HealthDay News) — Adults receiving chiropractic spinal manipulative therapy (SMT) for tension-type headache have a significantly lower likelihood of butalbital prescription, according to a study ...

The burden of respiratory syncytial virus (RSV) in young children continues to be high in the United States, according to a study published online Dec. 9 in JAMA Pediatrics. Heidi L. Moline, MD, MPH, ...